Title: Senior Engineer II
Company: Biogen Inc.
Location: Apex, North Carolina, United States
Abdullah Al Loman, PhD, senior engineer II at Biogen Inc., has been recognized by Marquis Who’s Who Top Engineers for dedication, achievements, and leadership in biopharmaceuticals.
With over a decade and a half of experience, Dr. Loman has established a successful career in biopharmaceuticals and biochemical engineering. Since 2021, he has served as senior engineer II at Biogen Inc., where he works as a pilot technical manager, defining process parameters for manufacturing drugs targeting neurodegenerative diseases. His prior roles include group leader and process development scientist at KBI Biopharma from 2019 to 2021, research scientist at 02 RegenTech LLC from 2016 to 2019, and postdoctoral researcher at The University of Akron from 2016 to 2017. He also served as a teaching assistant in 2012 and graduate research assistant from 2010 to 2016. Earlier in his career, he gained experience as a process engineering intern at Jamuna Fertilizer Company Limited in 2008.
Dr. Loman has made notable contributions to his field, co-authoring research published in Bioresource Technology and the Journal of Biotechnology. He also holds a patent for enzyme-based protein separation and enrichment from soy meal, wheat meal, and other plant-based materials. Among his achievements are four U.S. patents for innovative methods utilizing biological processes to create value-added products in food, biopharma, and agriculture. In light of his impressive undertakings, he was recognized with the Archer Daniels Midland Award from the American Oil Chemists’ Society in 2017, a dissertation fellowship from The University of Akron in 2016, and multiple honors for teaching, research, and academic excellence.
One of Dr. Loman’s key achievements is the development of a predictive technique for assessing manufacturing performance before large-scale execution, which has improved process development and reduced failures. He attributes his success to a strong drive to excel and the unwavering support of his family and coworkers, which he considers vital to his achievements. Looking to the future, he aims to leverage his work in rare diseases to improve patient access to innovative treatments by bridging the gap between research and commercialization, ensuring groundbreaking medications reach those in need.
For more information, please visit:
Contact Dr. Loman:
